Thank you for visiting my theme! Replace this with your message to visitors.
The Hong Kong Society of Nephrology was established since 1979. It is a non-profit making professional organization consisting of doctors, nurses and other allied health staff who are interested in renal diseases.
| Dr. Juan Jesus Carrero (Sweden) | Protein Energy Wasting in Haemodialysis; The Unescapable Fate | 2021/09 | |
| Dr. Wesley Visser (The Netherlands) | Call to Action: Nutritional Therapy Options to Prevent or Treat PEW | 2021/09 | |
| Dr. Silvio E. Inzucchi (USA) | When Endocrinologist, Cardiologist and Nephrologist Meet: The Tale of SGLT2 Inhibition | 2021/04 | |
| Prof. Ioannis Parodis (Sweden) | HKSN Webinar: Lupus Nephritis– Clinical Outcomes and Challenges in the 21st Century | 2021/04 | |
| Dr. Andrea LUK (HK) | Latest Updates on SGLT2 Inhibitors and Diabetic Kidney Disease | 2019/10 | |
| Dr. Phil MCFARLANE (USA) | Managing Cardiorenal Risk in Diabetes | 2019/10 | |
| Dr. Hon Lok TANG (HK) | Sudden Death in Haemodialysis Patients: Is It Preventable? | 2019/9 | |
| Prof. Masaomi NANGAKU (Japan) | Updates on Anaemia Management in Patients with Chronic Kidney Disease | 2019/9 | |
| Dr. Jack KC NG (HK) | Updates on Fluid Management in Peritoneal Dialysis Patients | 2019/9 | |
| Prof. Frederick WK TAM (UK) | Inflammatory Cytokines and Fibrotic Factors in Diabetic Nephropathy | 2019/9 | |
| Prof. Sydney CW TANG (HK) | IgA Nephropathy: The Landscape after 50 Years | 2019/9 | |
| Prof. Mark ROSENBERG (USA) | Slowing Progression of Chronic Kidney Diseases | 2019/9 | |
| Dr. Desmond YH YAP (HK) | Managing Renal Failure in Elderly - Clinical Challenges and Practical Considerations | 2019/9 | |
| Prof. Naoki KASHIHARA (Japan) | Aging Kidney – Pathophysiology and Clinical Implications | 2019/9 | |
| Ms. Sandy YH HUI (HK) | A Prospective Randomized Controlled Trial in Comparing the Usage of 95% Silver Nitrate Caustic Pencil Versus 2% Aqueous Chlorhexidine Swabstick in Treating Peritoneal Dialysis Catheter Exit-site Granuloma – A Pilot Study | 2019/9 | |
| Dr. Wai Yan LAU (HK) | Effect of Haemodialysis Membrane Permeability on Inflammatory Indices and Arterial Stiffness in Patients Receiving Home Haemodialysis: A Randomized Study | 2019/9 | |
| Dr. Tung Sen SHUM (HK) | Diagnostic and Prognostic Value of Glomerular PLA2R Deposition in Primary Membranous Nephropathy | 2019/9 | |
| Prof. Cheuk Chun SZETO (HK) | Messengers from the Kidney | 2019/9 | |
| Prof. Masaomi NANGAKU (Japan) | New Era of Diabetic Kidney Disease | 2019/9 | |
| Prof. Frederick WK TAM (UK) | Spleen Tyrosine Kinase (Syk): A Novel Therapeutic Target for Immune Mediated Kidney Diseases | 2019/9 | |
| Prof. Mark ROSENBERG (USA) | Reinventing Nephrology | 2019/9 |
| Darwin CK Lam | HDx Haemodialysis: A Single-Centre Experience | 2018/12 | |
| Julio Pascual | How Spain Became the World Leader in Organ Transplants | 2018/09 | |
| William Lee | Organ Donation in Hong Kong: the Struggle Continues | 2018/09 | |
| Kitty Jager | Donor kidney quality and patient outcomes | 2018/09 | |
| Stella Yiu | Role of Renal Tubular Wnt/Beta-catenin in the Proteinuric Kidney | 2018/09 | |
| Cheuk-Chun Szeto | Relation Between Peritoneal Dialysis Effluent microRNA Level and Longitudinal Change in Peritoneal Transport Characteristics | 2018/09 | |
| Ho Kwan Sin | Cardiac Calcification and Cardiovascular Disease in Peritoneal Dialysis Patients – a Cross-sectional Study | 2018/09 | |
| Sydney Tang | IgA Nephropathy: 50 years on | 2018/09 | |
| Mark Okusa | Neural Control of Inflammation in AKI | 2018/09 | |
| Carmine Zoccali | CKD as a Systemic Disease | 2018/09 | |
| Maggie Ma | Case Record from the Interhospital Meeting The First ABO-incompatible Kidney Transplant in Hong Kong | 2018/09 | |
| Julio Pascual | A decision for the elderly with renal failure: take an old kidney or remain on dialysis | 2018/09 | |
| Masaomi Nangaku | The AKI to CKD Continuum: a Clinical Perspective | 2018/09 | |
| Carmine Zoccali | Blood Pressure Targets in CKD Patients in the post SPRINT Era | 2018/09 | |
| Kitty Jager | Basic epidemiology presented in a palatable way | 2018/09 | |
| Mark Okusa | Immunoregulatory Role of Tissue Microenvironment in Kidney Injury | 2018/09 | |
| Nan Chen | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF PHI) Clinical Study Results | 2018/07 | |
| Hui Yao Lan | Basic Science Made Easy for the Nephrologist | 2018/07 | |
| Liz Lightstone | Lupus nephritis – concerns and management | 2018/07 | |
| Liz Lightstone | All a nephrologist should know about pregnancy | 2018/07 | |
| Carol Pollock | Discovery of SGLT2 inhibitors: from bench to bedside | 2018/07 | |
| SH Tsui | Toxicology for the practicing Nephrologists | 2018/07 | |
| Dirk R J Kuypers | Practical recommendations on long-term management of modifiable risks in kidney and liver transplant recipients –COMMIT Guidance | 2018/01 | |
| Robert A. Ritzel | Cost-effectiveness of basal insulin analogue from a regional perspective | 2018/03 |
| Peter J. Blankestijn | Present evidence on online hemodiafiltration | 2017/12 | |
| Mike Copland | An Overview of the BC Renal Agency | 2017/10 | |
| Suneet Singh | Innovations in PD: Focusing on PD Assist | 2017/10 | |
| Hui Yun Ho | Sodium Restriction Education Progream for Chronic Hemodialysis Patients | 2017/10 | |
| Steve Wong | Randomized Controlled Trial on Adjunctive Lavage for Severe Peritoneal Dialysis-related Peritonitis | 2017/10 | |
| Ivy Wong | BK Virus Infection in Renal Transplant Recipients: a Single-center Experience | 2017/10 | |
| Daniel TM Chan | Lupus Nephritis – Opus 2 | 2017/10 | |
| Susan Quaggin | An Eye Opening Revelation – Thrombotic Microangiopathies in the Molecular Era | 2017/10 | |
| David Harris | Improving Global Access to Integrated ESKD Care | 2017/10 | |
| Xueqing Yu | Generating a Big Database for Research in Nephrology | 2017/09 | |
| Hung Chun Chen | Heart and Kidney | 2017/09 | |
| Desmond Yap | Liver and Kidney | 2017/09 | |
| David Harris | Novel Therapeutic Approach for Renal Fibrosis | 2017/09 | |
| Masaomi Nangaku | Anemia in CKD | 2017/09 | |
| Mike Copland | Home HD Program Building and the Role of New Technologies | 2017/09 | |
| Chow Kai Ming | Case Record from the Interhospital Meeting | 2017/09 | |
| Pr L. Juillard | Expanded Hemodialysis – HDx Looking Beyond Traditional Uremic Toxicity | 2017/08 | |
| Adrian Liew | Biologics Therapy in Glomerulonephritis | 2017/07 | |
| Mariam Priya Alexander | Pathology of Complement Mediated Renal Disease | 2017/07 | |
| CC Szeto | Minimal change nephropathy: an update (for adults) | 2017/07 | |
| Min Chen | ANCA-associated vasculitis in China | 2017/07 | |
| Fan Fan Hou | The Profile and Temporal Change in Glomerular Diseases in China | 2017/07 | |
| Peter Mathieson | Membranous nephropathy: from bench to bedside | 2017/07 |
| Hui Yao Lan | Treatment of Diabetic Nephropathy: from Hyperglycemia to Hypertension and More |
2013/09 | |
| Roberto Minutolo | Evidence, experience and benefits of hemoglobin stability through simplified anemia management |
2013/09 | |
| R. J. Desnick | FABRY DISEASE | 2013 | |
| Dr. Patrick Biggar | Improving sHPT Treatment for Better Patient Outcomes | 2013 | |
| R. J. Desnick | FABRY DISEASE | 2013 | |
| Joshua M. Thurman, MD | aHUS: Pathogenesis,Diagnosis, and Treatment | 2013 |
